Advertisement

Topics

Ligand Pharma Earns Milestone Payment On FDA Approval Of Baxdela

09:34 EDT 20 Jun 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) announced that partner Melinta Therapeutics, a privately held company, announced on Monday that the U.S. FDA has approved Baxdela (delaflo...

Original Article: Ligand Pharma Earns Milestone Payment On FDA Approval Of Baxdela

NEXT ARTICLE

More From BioPortfolio on "Ligand Pharma Earns Milestone Payment On FDA Approval Of Baxdela"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...